The Elasticity of Pharmaceutical Innovation

That is the title of a new USC white paper by Darren Filson, Karen Van Nuys, Darius Lakdawalla and Dana Goldman with the subtitle “How Much Does Revenue Drive New Drug Development?” What is the elasticity of innovation? It measures the percentage change in innovation—using the flow of new drugs approvals, or Phase 1, 2,…

Read More

Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys

Sarepta Therapeutics said the Duchenne muscular dystrophy patient recently had a cytomegalovirus infection, which can damage the liver and may have contributed to the fatality. It’s the first patient death out of more than 800 patients treated with Elevidys, a gene therapy for the rare muscle-wasting disease. The post Liver Failure-Associated Death Reported in Patient…

Read More

Congress passes Full-Year Continuing Resolution Bill, maintaining global health funding at prior year levels

On March 15, 2025, the President signed a full-year “continuing resolution” (CR) that continues funding the federal government through the rest of the fiscal year. It maintains U.S. global health funding at the prior year (FY 2024) level ($10.8 billion).[i] The Full-Year Continuing Appropriations and Extensions Act, 2025, which was passed by the House on…More

Read More